巨乳+群p+在线,国产三级免费影视,sm调教的小说,藏品电影一共有几部,琪琪影院 77vcd,你是我学生又怎样小说免费阅读全文,追爱 电影 2016,尤物网站视频免费看,日韩午夜福利码高清完整版

歡迎來(lái)到上海谷研實(shí)業(yè)有限公司網(wǎng)站!
咨詢電話:18321818584
Products產(chǎn)品中心
首頁(yè) > 產(chǎn)品中心 > 蛋白/抗體 > 一抗 > B細(xì)胞轉(zhuǎn)錄激活因子抗體

B細(xì)胞轉(zhuǎn)錄激活因子抗體

簡(jiǎn)要描述:B細(xì)胞轉(zhuǎn)錄激活因子抗體免 疫 原;KLH conjugated synthetic peptide derived from human BATF: 31-125/125

  • 產(chǎn)品型號(hào):GOY-01K1239
  • 廠商性質(zhì):科研
  • 更新時(shí)間:2023-10-24 00:00:00
  • 訪  問  量:173

產(chǎn)品分類

Product Category
查看全部

相關(guān)文章

Related Articles

詳細(xì)介紹

B細(xì)胞轉(zhuǎn)錄激活因子抗體


產(chǎn)品名稱

英文名稱

貨號(hào)

B細(xì)胞轉(zhuǎn)錄激活因子抗體

BATF

GOY-01K1239

商品屬性:

英文名稱: BATF

中文名:B細(xì)胞轉(zhuǎn)錄激活因子抗體

   名;Activating transcription factor B; B ATF; B-ATF; B-cell-activating transcription factor; Basic leucine zipper transcription factor like; Basic leucine zipper transcriptional factor ATF like; Basic leucine zipper transcriptional factor ATF-like; Batf; BATF_HUMAN; BATF1; SF HT activated gene 2 protein; SF-HT-activated gene 2 protein; SFA 2; SFA-2; SFA2.

研究領(lǐng)域;細(xì)胞生物  信號(hào)轉(zhuǎn)導(dǎo)  淋巴細(xì)胞  t-淋巴細(xì)胞  b-淋巴細(xì)胞  表觀遺傳學(xué)

抗體來(lái)源;Rabbit

克隆類型;Polyclonal

交叉反應(yīng);(predicted: Human, Mouse, Rat, )

產(chǎn)品應(yīng)用;ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

理論分子量;14kDa

細(xì)胞定位;細(xì)胞核 細(xì)胞漿

   狀;Liquid

   度;1mg/ml

原;KLH conjugated synthetic peptide derived from human BATF: 31-125/125

   型;IgG

純化方法;affinity purified by Protein A

液;0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存條件;Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

注意事項(xiàng);This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

產(chǎn)品介紹:

B-ATF is a nuclear basic leucine zipper protein that belongs to the AP-1/ATF superfamily of transcription factors. The leucine zipper of B-ATF mediates dimerization with members of the Jun family of proteins. The B-ATF protein does not homodimerize efficiently, but rather forms a heterodimer preferentially with c-Jun. The B-ATF/c-Jun protein complex can interact with DNA containing a consensus binding site for AP-1, suggesting that B-ATF functions as a tissue-specific modulator of the AP-1 transcription complex in human cells. B-ATF also associates with IFP35, a leucine zipper protein that translocates to the nucleus following IFN treatment. The gene encoding B-ATF, also designated SFA-2, is strongly expressed in mature T and B lymphocytes, and is up-regulated after transformation by human T-cell leukemia virus type I.

Function:

AP-1 family transcription factor that controls the differentiation of lineage-specific cells in the immune system: specifically mediates the differentiation of T-helper 17 cells (Th17), follicular T-helper cells (TfH), CD8(+) dendritic cells and class-switch recombination (CSR) in B-cells. Acts via the formation of a heterodimer with JUNB that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3'. The BATF-JUNB heterodimer also forms a complex with IRF4 (or IRF8) in immune cells, leading to recognition of AICE sequence (5'-TGAnTCA/GAAA-3'), an immune-specific regulatory element, followed by cooperative binding of BATF and IRF4 (or IRF8) and activation of genes. Controls differentiation of T-helper cells producing interleukin-17 (Th17 cells) by binding to Th17-associated gene promoters: regulates expression of the transcription factor RORC itself and RORC target genes such as IL17 (IL17A or IL17B). Also involved in differentiation of follicular T-helper cells (TfH) by directing expression of BCL6 and MAF. In B-cells, involved in class-switch recombination (CSR) by controlling the expression of both AICDA and of germline transcripts of the intervening heavy-chain region and constant heavy-chain region (I(H)-C(H)). Following infection, can participate to CD8(+) dendritic cell differentiation via interaction with IRF4 and IRF8 to mediate cooperative gene activation. Regulates effector CD8(+) T-cell differentiation by regulating expression of SIRT1. Following DNA damage, part of a differentiation checkpoint that limits self-renewal of hematopoietic stem cells (HSCs): up-regulated by STAT3, leading to differentiation of HSCs, thereby restricting self-renewal of HSCs.

 

 

1.png

4.png

多克隆抗體制備:

我公司合成抗原,保證陽(yáng)性血清和抗體ELISA效價(jià)達(dá)到1:32000,由蛋白抗原制備的多抗,保證WB檢測(cè)結(jié)果是陽(yáng)性。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。

鼠單克隆抗體制備:

客戶可根據(jù)項(xiàng)目實(shí)際需求情況靈活選擇進(jìn)行,我公司將為您的項(xiàng)目提供專業(yè)的建議。在制備過(guò)程中,與客戶互動(dòng)驗(yàn)證,確保最終制備的抗體ELISA陽(yáng)性血清檢測(cè)達(dá)到合同要求的同時(shí),也能滿足客戶抗體最終應(yīng)用驗(yàn)證需求。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。

圖片1.png

重組抗體表達(dá)服務(wù):

重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無(wú)法做到的。我公司已搭建好的抗體測(cè)序、重組抗體表達(dá)等先進(jìn)平臺(tái),能為客戶提供各種類型的重組抗體表達(dá)服務(wù),包含鼠源單克隆抗體構(gòu)建及表達(dá)、更換恒定區(qū)亞型的嵌合抗體表達(dá),抗體人源化改造及表達(dá)等服務(wù)。

單項(xiàng)免疫學(xué)及檢測(cè)服務(wù):

我公司也為客戶提供單項(xiàng)免疫學(xué)和檢測(cè)服務(wù),如動(dòng)物免疫、動(dòng)物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標(biāo)記)、以及ELISA,WB,IHC,DB等檢測(cè)服務(wù)。

抗體定制服務(wù):

已注冊(cè)商標(biāo),主要用于抗體藥物發(fā)現(xiàn)和開發(fā),是我公司針對(duì)有特定應(yīng)用要求和各種模型測(cè)試的客戶量身定制的專業(yè)服務(wù),主要面向工業(yè)客戶。

產(chǎn)品咨詢

留言框

  • 產(chǎn)品:

  • 留言內(nèi)容:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 詳細(xì)地址:

  • 驗(yàn)證碼:

上海谷研實(shí)業(yè)有限公司
  • 聯(lián)系人:銷售部
  • 地址:上海市嘉定區(qū)澄瀏公路52號(hào)盛創(chuàng)企業(yè)
  • 郵箱:[email protected]
  • 手機(jī):18321818584 / 15026555973
關(guān)注我們

歡迎您關(guān)注我們的微信了解更多信息

掃一掃
關(guān)注我們
版權(quán)所有 © 2022 上海谷研實(shí)業(yè)有限公司 All Rights Reserved    備案號(hào):滬ICP備12048703號(hào)-1    sitemap.xml
本公司所有產(chǎn)品僅供科學(xué)實(shí)驗(yàn),不做其他科學(xué)實(shí)驗(yàn)外的使用!